Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iasis Pharmaceuticals is a prominent Greek pharmaceutical company specializing in the research, development, production, and export of pharmaceutical products, medical devices, and cosmetics. The company maintains a strong focus on niche therapeutic categories and innovative herbal medicinal products, notably those derived from Chios Mastiha. Operating state-of-the-art, EU GMP-licensed manufacturing and R&D facilities in Kamatero and Koropi, Greece, Iasis Pharma is recognized for its expertise in specialized formulations such as effervescent tablets, oral liquids, and nasal sprays. The company has a significant international presence, exporting its diverse portfolio to over 36 countries across Europe, the Middle East, Africa, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iasis.